Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Celcuity Inc (NQ: CELC )

13.66 +0.47 (+3.56%)
Streaming Delayed Price Updated: 11:55 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 43,733
Open 13.40
Bid (Size) 13.62 (7)
Ask (Size) 13.70 (7)
Prev. Close 13.19
Today's Range 13.40 - 14.01
52wk Range 11.51 - 22.04
Shares Outstanding 37,028,733
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Earnings Scheduled For November 14, 2024
Via Benzinga
Insights into Celcuity's Upcoming Earnings
Via Benzinga

Performance

YTD
-7.58%
-7.58%
1 Month
-12.49%
-12.49%
3 Month
-21.72%
-21.72%
6 Month
-9.89%
-9.89%
1 Year
-2.29%
-2.29%

More News

Read More
CELC Stock Earnings: Celcuity Beats EPS for Q2 2024
Via InvestorPlace
CELC Stock Earnings: Celcuity Beats EPS for Q1 2024
Via InvestorPlace
CELC Stock Earnings: Celcuity Beats EPS for Q4 2023
Via InvestorPlace
Recap: Celcuity Q4 Earnings
Via Benzinga
Celcuity Earnings Preview
Via Benzinga
Celcuity Inc. Announces $50 Million Private Placement
Via ACCESSWIRE
Preview: Celcuity's Earnings
Via Benzinga
A Preview Of Celcuity's Earnings
Via Benzinga
Earnings Scheduled For March 27, 2024
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
The 7 Best Short-Squeeze Stocks to Buy Now: September 2023
Via InvestorPlace
Earnings Scheduled For November 13, 2023
Via Benzinga
A Preview Of Celcuity's Earnings
Via Benzinga
7 Short-Squeeze Stocks That Actually Might Make Sense
Via InvestorPlace
10 Short Squeeze Stocks To Watch: Yellow Corporation, Getty Images, Tupperware And More
Via Benzinga
Celcuity Set to Join Russell 2000 and 3000 Indexes
Via ACCESSWIRE
Celcuity to Participate in Upcoming Craig-Hallum and Jefferies Investor Conferences
Via ACCESSWIRE
Celcuity Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Updates
Via ACCESSWIRE
Celcuity Presents Updated Results from Phase 1b Study of Gedatolisib in Treatment-Naïve Patients at the 2023 ESMO Breast Cancer Annual Congress
Via ACCESSWIRE
Celcuity Inc. Schedules Release of First Quarter 2023 Financial Results and Webcast/Conference Call
Via ACCESSWIRE
Celcuity to Present Updated Results for Treatment-Naïve Patients from Phase 1b Study of Gedatolisib at the 2023 ESMO Breast Cancer Annual Congress
Via ACCESSWIRE
Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Gynecological Cancer Models at AACR Annual Meeting 2023
Via ACCESSWIRE
Celcuity to Participate in 22nd Annual Needham Virtual Healthcare Conference
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.